Aldevron, a leading manufacturer of plasmid DNA, proteins and mRNA, today announced the sale of its Germany based antibody discovery business. Brian Walters, current president of the business unit and longtime employee of Aldevron, led a group of investors to purchase the business for an undisclosed amount. The transaction is effective immediately.
Attracting one of med-tech’s most accomplished executives, Aldevron has named Kevin Ballinger as Chief Executive Officer, effective July 13, 2020. Aldevron’s co-founder, Michael Chambers, has been named Executive Chairman of the board. Chambers initiated the transition to allow him to focus on innovation, corporate strategy and working with clients and industry thought leaders to develop new technologies that enable genetic medicine. Ballinger will assume day-to-day operational leadership of Aldevron, facilitating the company’s rapid growth.
Fargo, N.D., based company increasing capacity to better serve
rapidly growing biotech industry
Aldevron officially broke ground on its 14-acre campus expansion at its global headquarters in Fargo, North Dakota, August 19. Three buildings are planned, with construction of its next GMP manufacturing facility starting first.
Aldevron appoints presidents of its Antibody and Protein business units, strengthening its position as a global leader in biologics manufacturing
Brian Walters, President of its Antibody Business Unit, and Tom Foti now President of its Protein Business Unit
Aldevron has named Brian Walters, President of its antibody business unit and Tom Foti President of its protein business unit.
Aldevron has expanded its leadership team by appointing Michelle Berg President of its GMP nucleic acids business unit. She will report to Michael Chambers, Aldevron’s founder and CEO.
Andy Rodgers has joined Aldevron as its Director of Operational Excellence. In his position, Rodgers will be responsible for developing, implementing and managing strategies and objectives to ensure the achievement of the company’s goals to improve performance, quality, delivery and cost.
Lance Monilaws of Aldevron has been promoted as its Director of Industrial Project Management. In his position, Monilaws will direct large capital projects with emphasis in facility expansion, renovation and campus planning. He will also manage various operational initiatives and strategies, including but not limited to construction and industrial technology.
Ally Hauser of Aldevron has been promoted to Director of Client Relations for Protein Services. In her position, Hauser will lead new projects and initiatives to expand research grade and cGMP protein services to the benefit of our clients.
Reported by Patrick Springer of the Forum of Fargo-Moorhead